Arcturus Therapeutics Holdings Inc.ARCTNASDAQ

Revenue (LTM)

$67M

-51.4% YoY

Net Income (LTM)

$-66M

+18.7% YoY

Free Cash Flow

$-74M

Revenue CAGR (5Y)

+52.7%

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	12	206↑1564.8%	158↓23.3%	138↓12.3%	67↓51.4%
Gross Profit	12	206↑1564.8%	158↓23.3%	138↓12.3%	64↓53.6%
Operating Income	-203	12↑106.0%	-78↓742.2%	-96↓22.3%	-75↑21.7%
Net Income	-204	9↑104.6%	-30↓417.9%	-81↓172.3%	-66↑18.7%
EBITDA	-202	14↑106.8%	-24↓276.3%	-77↓220.3%	-72↑7.1%
EPS Diluted	-7.74	0.35↑104.5%	-1.12↓420.0%	-3.00↓167.9%	-2.40↑20.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	370	392↑5.8%	292↓25.5%	237↓18.8%	231↓2.6%
Total Current Assets	379	403↑6.4%	387↓4.2%	306↓20.9%	241↓21.1%
Total Assets	393	450↑14.7%	429↓4.7%	344↓19.9%	271↓21.2%
Total Current Liabilities	100	127↑27.6%	82↓35.4%	65↓20.1%	36↓44.5%
Total Liabilities	165	180↑9.4%	151↓16.2%	103↓31.7%	57↓44.6%
Total Equity	228	270↑18.4%	279↑3.0%	241↓13.5%	214↓11.2%
Total Debt	69	95↑37.0%	30↓68.1%	29↓5.5%	25↓12.4%
Net Debt	-301	-297↑1.4%	-262↑11.9%	-208↑20.4%	-206↑1.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-135	32↑123.7%	-18↓156.6%	-60↓230.1%	-74↓24.3%
Capital Expenditure	-3	-8↓126.8%	-3↑62.5%	-1↑77.7%	-0↑64.5%
Free Cash Flow	-138	24↑117.5%	-21↓186.5%	-60↓187.6%	-74↓23.0%
Stock-Based Comp	29	31↑5.9%	35↑13.2%	38↑9.6%	25↓33.1%
Net Change in Cash	-90	21↑123.7%	-45↓310.6%	-55↓21.9%	-61↓11.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance